Excision Medical develops the Excision Medical Leaflet Excision System to allow physicians to target and excise one or more aortic valve leaflets while accounting for patients' hemodynamic needs. The company focuses on lifetime management of aortic stenosis through leaflet modification technology. It intends to use proceeds from the recent financing to advance its catheter systems. Excision raised $2.5M in the financing announced in September 2022. The round was led by the company's internal team, and Drs. James McCabe and Adam Greenbaum joined as scientific advisory board members. The company was founded in 2020 by Greg Walters, Dr. Gary Roubin, Dr. David Wood and Dr. Janarthanan Sathananthan.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2022